BG105859A - Тетрахидропиранови производни и тяхното използване като терапевтични вещества - Google Patents
Тетрахидропиранови производни и тяхното използване като терапевтични вещества Download PDFInfo
- Publication number
- BG105859A BG105859A BG105859A BG10585901A BG105859A BG 105859 A BG105859 A BG 105859A BG 105859 A BG105859 A BG 105859A BG 10585901 A BG10585901 A BG 10585901A BG 105859 A BG105859 A BG 105859A
- Authority
- BG
- Bulgaria
- Prior art keywords
- alkyl
- alkoxy
- formula
- phenyl
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9906480.0A GB9906480D0 (en) | 1999-03-19 | 1999-03-19 | Therapeutic agents |
GBGB9924616.7A GB9924616D0 (en) | 1999-10-18 | 1999-10-18 | Therapeutic agents |
PCT/GB2000/000977 WO2000056728A1 (en) | 1999-03-19 | 2000-03-16 | Tetrahydropyran derivatives and their use as therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
BG105859A true BG105859A (bg) | 2002-04-30 |
Family
ID=26315315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG105859A BG105859A (bg) | 1999-03-19 | 2001-08-30 | Тетрахидропиранови производни и тяхното използване като терапевтични вещества |
Country Status (23)
Country | Link |
---|---|
US (1) | US6458830B1 (de) |
EP (1) | EP1165540B1 (de) |
JP (1) | JP2002540107A (de) |
KR (1) | KR20010113773A (de) |
CN (1) | CN1344264A (de) |
AT (1) | ATE247096T1 (de) |
AU (2) | AU3304400A (de) |
BG (1) | BG105859A (de) |
BR (1) | BR0009127A (de) |
CA (1) | CA2367985A1 (de) |
CO (1) | CO5150225A1 (de) |
CZ (1) | CZ20013377A3 (de) |
DE (1) | DE60004504T2 (de) |
EA (1) | EA200100902A1 (de) |
EE (1) | EE200100491A (de) |
ES (1) | ES2203434T3 (de) |
HU (1) | HUP0200441A3 (de) |
IL (1) | IL144236A0 (de) |
NO (1) | NO20014529L (de) |
PE (1) | PE20001556A1 (de) |
PL (1) | PL350123A1 (de) |
SK (1) | SK13322001A3 (de) |
WO (2) | WO2000056728A1 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10001785A1 (de) * | 2000-01-18 | 2001-07-19 | Boehringer Ingelheim Pharma | NK¶1¶-Rezeptor-Antagonisten zur Behandlung des Restless Legs Syndroms |
GB0017256D0 (en) | 2000-07-13 | 2000-08-30 | Merck Sharp & Dohme | Therapeutic agents |
GB0020721D0 (en) | 2000-08-22 | 2000-10-11 | Merck Sharp & Dohme | Therapeutic agents |
PE20020444A1 (es) | 2000-09-22 | 2002-06-14 | Merck & Co Inc | Antagonistas de receptores de taquiquinina zwitterionica |
CA2433835A1 (en) | 2001-01-17 | 2002-07-25 | Merck Sharp & Dohme Limited | Tetrahydropyran derivatives as neurokinin receptor antagonists |
GB0121874D0 (en) * | 2001-09-10 | 2001-10-31 | Merck Sharp & Dohme | Therapeutic agents |
GB0217068D0 (en) * | 2002-07-23 | 2002-08-28 | Merck Sharp & Dohme | Therapeutic agents |
EP1562975A2 (de) * | 2002-10-25 | 2005-08-17 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Steroide welche gruppen zur nachahmung von superoxidase dismutase sowie stickoxid donorgruppen beinhalten und ihre verwendung in der darstellung von medikamenten |
US20060166894A1 (en) * | 2002-11-29 | 2006-07-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Ace-inhibitors having antioxidant and no-donor activity |
AU2004218228A1 (en) * | 2003-03-07 | 2004-09-16 | Merck Sharp & Dohme Limited | Tetrahydropyran compounds as tachykinin antagonists |
WO2006027345A2 (en) * | 2004-09-08 | 2006-03-16 | Altana Pharma Ag | Novel 3-thia-10-aza-phenanthrene derivatives |
EP1819661B1 (de) * | 2004-11-30 | 2009-04-22 | Mallinckrodt, Inc. | Verfahren zur kristallisierung von benzphetamin |
CN101203512A (zh) * | 2005-04-22 | 2008-06-18 | 第一三共株式会社 | 杂环化合物 |
CN100395242C (zh) * | 2006-06-08 | 2008-06-18 | 华东理工大学 | 烷氧基萘和萘醌类吡喃碳糖苷化合物及其制备方法 |
DE102007010077B4 (de) * | 2007-02-28 | 2010-04-08 | RUHR-UNIVERSITäT BOCHUM | [1,3]-Dioxane zur Modulation von GABAa-Rezeptoren |
ES2672099T3 (es) | 2011-07-04 | 2018-06-12 | Irbm - Science Park S.P.A. | Antagonistas del receptor NK-1 para el tratamiento de la neovascularización corneal |
WO2014039504A1 (en) * | 2012-09-04 | 2014-03-13 | Lauren Sciences Llc | Bolaamphiphilic compounds, compositions and uses thereof |
CA2951259A1 (en) | 2014-06-06 | 2015-12-10 | Flexus Biosciences, Inc. | Immunoregulatory agents |
AR102537A1 (es) | 2014-11-05 | 2017-03-08 | Flexus Biosciences Inc | Agentes inmunomoduladores |
MX2017005462A (es) * | 2014-11-05 | 2017-07-28 | Flexus Biosciences Inc | Agentes inmunorreguladores. |
UY36390A (es) | 2014-11-05 | 2016-06-01 | Flexus Biosciences Inc | Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen |
HU231150B1 (hu) | 2017-03-13 | 2021-03-29 | Richter Gedeon Nyrt | Eljárás racém 3-alkilpiperidin-3-karbonsav-etil-észterek optikai izomerjeinek elválasztására |
WO2019156074A1 (ja) * | 2018-02-06 | 2019-08-15 | 第一三共株式会社 | アミノアルキル化合物 |
US20210015834A1 (en) | 2018-02-26 | 2021-01-21 | Ospedale San Raffaele S.R.L. | Nk-1 antagonists for use in the treatment of ocular pain |
US20230134843A1 (en) | 2020-03-11 | 2023-05-04 | Ospedale San Raffaele S.R.L. | Treatment of stem cell deficiency |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9301920D0 (en) | 1993-02-01 | 1993-03-17 | Foundation For Ethnobiology Th | Polycetylenes |
-
2000
- 2000-03-10 CO CO00017612A patent/CO5150225A1/es unknown
- 2000-03-13 PE PE2000000218A patent/PE20001556A1/es not_active Application Discontinuation
- 2000-03-16 AU AU33044/00A patent/AU3304400A/en not_active Abandoned
- 2000-03-16 CA CA002367985A patent/CA2367985A1/en not_active Abandoned
- 2000-03-16 AT AT00911045T patent/ATE247096T1/de not_active IP Right Cessation
- 2000-03-16 PL PL00350123A patent/PL350123A1/xx not_active Application Discontinuation
- 2000-03-16 CZ CZ20013377A patent/CZ20013377A3/cs unknown
- 2000-03-16 EP EP00911045A patent/EP1165540B1/de not_active Expired - Lifetime
- 2000-03-16 HU HU0200441A patent/HUP0200441A3/hu unknown
- 2000-03-16 BR BR0009127-8A patent/BR0009127A/pt not_active Application Discontinuation
- 2000-03-16 SK SK1332-2001A patent/SK13322001A3/sk unknown
- 2000-03-16 EA EA200100902A patent/EA200100902A1/ru unknown
- 2000-03-16 WO PCT/GB2000/000977 patent/WO2000056728A1/en not_active Application Discontinuation
- 2000-03-16 US US09/936,343 patent/US6458830B1/en not_active Expired - Fee Related
- 2000-03-16 IL IL14423600A patent/IL144236A0/xx unknown
- 2000-03-16 DE DE60004504T patent/DE60004504T2/de not_active Expired - Fee Related
- 2000-03-16 EE EEP200100491A patent/EE200100491A/xx unknown
- 2000-03-16 CN CN00805114A patent/CN1344264A/zh active Pending
- 2000-03-16 ES ES00911045T patent/ES2203434T3/es not_active Expired - Lifetime
- 2000-03-16 WO PCT/GB2000/000974 patent/WO2000056727A1/en active IP Right Grant
- 2000-03-16 KR KR1020017011885A patent/KR20010113773A/ko not_active Application Discontinuation
- 2000-03-16 JP JP2000606588A patent/JP2002540107A/ja not_active Withdrawn
- 2000-03-16 AU AU33042/00A patent/AU746251B2/en not_active Ceased
-
2001
- 2001-08-30 BG BG105859A patent/BG105859A/bg unknown
- 2001-09-18 NO NO20014529A patent/NO20014529L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EE200100491A (et) | 2002-12-16 |
WO2000056727A1 (en) | 2000-09-28 |
ATE247096T1 (de) | 2003-08-15 |
AU3304200A (en) | 2000-10-09 |
CO5150225A1 (es) | 2002-04-29 |
ES2203434T3 (es) | 2004-04-16 |
AU746251B2 (en) | 2002-04-18 |
DE60004504D1 (de) | 2003-09-18 |
IL144236A0 (en) | 2002-05-23 |
NO20014529L (no) | 2001-11-13 |
HUP0200441A3 (en) | 2002-09-30 |
CN1344264A (zh) | 2002-04-10 |
CZ20013377A3 (cs) | 2002-02-13 |
SK13322001A3 (sk) | 2002-02-05 |
KR20010113773A (ko) | 2001-12-28 |
US6458830B1 (en) | 2002-10-01 |
CA2367985A1 (en) | 2000-09-28 |
PE20001556A1 (es) | 2001-01-13 |
HUP0200441A2 (hu) | 2002-07-29 |
JP2002540107A (ja) | 2002-11-26 |
AU3304400A (en) | 2000-10-09 |
DE60004504T2 (de) | 2004-06-24 |
WO2000056728A1 (en) | 2000-09-28 |
PL350123A1 (en) | 2002-11-04 |
EA200100902A1 (ru) | 2002-02-28 |
EP1165540A1 (de) | 2002-01-02 |
NO20014529D0 (no) | 2001-09-18 |
EP1165540B1 (de) | 2003-08-13 |
BR0009127A (pt) | 2001-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG105859A (bg) | Тетрахидропиранови производни и тяхното използване като терапевтични вещества | |
US5728695A (en) | Spiroketal derivatives, compositions containing them and their use as therapeutic agents | |
AU715558B2 (en) | Spiro-piperidine derivatives and their use as tachykinin antagonists | |
AU713095B2 (en) | 3-benzylaminopyrrolidines and -piperidines as tachykinin receptor antagonists | |
US5985896A (en) | Piperidine and morpholine derivatives and their use as therapeutic agents | |
JP3071467B2 (ja) | 置換モルホリン誘導体およびその治療剤としての使用 | |
IL265627A (en) | Cystic Fibrosis Transmembrane Conductive Menstrual Module, Pharmaceutical Preparations, Methods of Treatment, and Process for Preparing the Cyst | |
HU217428B (hu) | 3-(5-Tetrazolil-benzil)-amino-piperidin-származékok, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyászati készítmények | |
JP6254075B2 (ja) | カリウムチャネル遮断剤としてのアミン誘導体 | |
EA032559B1 (ru) | Бициклические аннелированные гетероарильные или арильные соединения и их применение в качестве ингибиторов irak4 | |
GB2302689A (en) | N-oxides of morpholine derivatives and their use as therapeutic agents | |
WO1997001553A1 (en) | Piperidine and morpholine derivatives and their use as therapeutic agents | |
JP2000500154A (ja) | モルホリン誘導体及び治療薬としてのそれらの使用 | |
WO2002016344A1 (en) | Tetrahydropyran derivatives as nk-1 receptor antagonists | |
MXPA01009408A (en) | Tetrahydropyran derivatives and their use as therapeutic agents | |
CA2237638A1 (en) | Spiro-piperidine derivatives and their use as tachykinin antagonists |